Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. - Wikidata - wikimedia - TriplyDB

Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation.

Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation.

http://www.wikidata.org/entity/Q34282217

about

Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation Regulatory myeloid cells in transplantation Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells.Tolerogenic dendritic cells and their role in transplantation.Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation.Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation.Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs.Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12 Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease.Origin and biology of the allogeneic response Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.Donor dendritic cell-derived exosomes promote allograft-targeting immune response Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu.Old game, new players: Linking classical theories to new trends in transplant immunology.What is the role of antigen-processing mechanisms in autologous tolerogenic dendritic cell therapy in organ transplantation?Dendritic cell therapy for Type 1 diabetes suppression.Experimental models to investigate the function of dendritic cell subsets: challenges and implications.Cell therapy using tolerogenic dendritic cells in transplantation.Transplant tolerance: new insights and strategies for long-term allograft acceptance.Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles.Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells Tolerogenic dendritic cell therapy in organ transplantation.Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?Upregulation of Heme Oxygenase-1 Endues Immature Dendritic Cells With More Potent and Durable Immunoregulatory Properties and Promotes Engraftment in a Stringent Mouse Cardiac Allotransplant Model.TIGIT iTregs elicited by human regulatory macrophages control T cell immunity

P2860

Q21131223-CBECE1FC-4419-4002-93EE-D50AC61081F5 Q21284774-2E13A553-6965-4FB3-BC20-6E8C1A6A6554 Q26767458-03039CE1-4C81-4E4D-B1EA-351D4B9E64E4 Q26999875-883B377F-6375-4220-BD28-33A2315350B1 Q30278837-7E059E28-D447-4DE9-AB3C-EA75AC35F098 Q34379951-3D617247-FDB7-455A-8C4B-716045462626 Q35341379-B5591453-DB76-43A8-BD5B-50A12C492E83 Q35692028-EBB789B7-8A34-4CFA-AAC3-1CEB7F6AB296 Q35865098-BB32FB69-71C9-4FF1-83E3-BA97F84E0557 Q36002657-A30A3DB9-4A5D-42E2-B167-0C27CEDD4224 Q36238593-091A67BE-22FB-47A6-A5D4-C7A4E11959D9 Q36578322-3FF14C26-5E42-4508-B841-6A421BC907F0 Q36761540-9422C8EF-2317-4AED-947A-1657C50EF35F Q36880118-FF2EA2A6-066B-4C50-8225-D155E91DA0C2 Q37040247-3F5E2D95-EA3C-4D04-9CFE-195816B60026 Q37077325-1CA783E8-93A3-47C3-9496-42237A270EB5 Q37137864-69CBF380-2BCA-4D99-B306-62981684C081 Q37316849-918BDAB1-149D-49C2-B22C-1071FF7C3E9B Q37662989-75CF9A29-9070-4D8C-8A9F-8B486AFF311E Q37869483-92702862-ACC4-444C-A1A7-969C2941C9AB Q38059518-CABEFE3A-1813-4476-A311-BA232DEDB270 Q38071421-3C8DAA23-7F0A-40FD-80F5-A8AFEE63AF51 Q38078105-591FE050-8BD3-447B-8D81-209090CD4CE5 Q38114067-20D5E692-02E4-4918-A07E-0E006E6FF56B Q38256369-0548A508-5759-4C81-BEC2-3430378A007D Q38339535-B4A57E6B-7B51-4C2D-A336-A1521AAB0014 Q38682156-CC23079F-E4AC-4768-B571-7D785E6574C9 Q38955064-B9BCBC64-F29C-4AB4-815A-A8057A59277C Q39013872-12DDF133-3F66-43E2-AB46-CE0CF2CE15DE Q47121682-BF144650-B9EB-46A3-BD7C-5A4486B42D7B Q50023625-57AE4F72-3B90-4475-8AF1-21371A11A158 Q50177437-C0B3DD75-B0C5-4C41-87AF-23985D06A0AB Q50993283-D76F38C2-E5A2-49AE-9D5C-AB4B9BA8294E Q52665595-0A0EE42B-F91C-4B17-949B-D8D94C85CF94 Q55662835-23827026-61FB-4220-B68F-9FB64DD22568 Q56967224-5AE2B702-8887-4308-8338-54330D0C825A

P2860

Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation.

http://www.wikidata.org/entity/Q34282217

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Endogenous dendritic cells med ...... itic cells in transplantation.

@ast

Endogenous dendritic cells med ...... itic cells in transplantation.

@en

Endogenous dendritic cells med ...... itic cells in transplantation.

@nl

type

label

Endogenous dendritic cells med ...... itic cells in transplantation.

@ast

Endogenous dendritic cells med ...... itic cells in transplantation.

@en

Endogenous dendritic cells med ...... itic cells in transplantation.

@nl

prefLabel

Endogenous dendritic cells med ...... itic cells in transplantation.

@ast

Endogenous dendritic cells med ...... itic cells in transplantation.

@en

Endogenous dendritic cells med ...... itic cells in transplantation.

@nl

P1433

Q34282217-DA9F86D0-6F24-49C5-9D9A-CC2F14D9811A

P1476

Q34282217-04C4E738-F6A6-404C-BBD2-7A134B5B9EA8

P2093

Q34282217-0098ECC5-8321-41AE-B6A6-5EC1B37B4C39

Q34282217-2FAC0203-7424-4176-99A1-4DE755662A4B

Q34282217-3B8D588B-7CE8-4528-8D08-AE92D5B67FA5

Q34282217-3CFB8F43-29FF-48CC-8109-9F5C2175F6DE

Q34282217-3E4AA57C-FBBC-470E-BD92-404948FBE392

Q34282217-C0AD1A2E-C4F7-4AA7-BDEA-BEEFF4407818

Q34282217-DE2A1871-239F-41F5-A244-1C0B749FAF2F

Q34282217-E82A2DD0-084E-4BF0-9787-00978A0B1F7F

Q34282217-F81F418B-936C-4EE2-8A47-5423D493BD07

P2860

Q34282217-06655ED8-E10A-4BF1-A63B-3A687D0832ED

Q34282217-11BE3A3F-86F9-401D-9BEF-87B003C5B8E7

Q34282217-1D312B81-B1A5-4761-AF4F-B776650A45DF

Q34282217-26AA1105-1116-4099-A8B1-058D45C13D31

Q34282217-288535A2-C422-4D43-A334-A5469753906F

Q34282217-2B6ECCEE-E1F1-43AA-9611-ADAC34D38747

Q34282217-344765CF-84D8-43C9-8B5B-F1C67661F2AC

Q34282217-360A6403-74BF-4732-A1A5-A89FBF2C4E2F

Q34282217-383351B2-55EF-4DD9-812D-9028C3E2E6F3

Q34282217-38CF60DF-ED89-4DEC-891D-8AE7B7BE7604

P304

Q34282217-2148970C-BAA0-499F-A76F-4A94577CB50E

P31

Q34282217-E00B9EE7-85A9-4284-AB66-0D83B6444C8D

P356

Q34282217-32DF0E8F-0582-4F27-B0F0-D05F91556DFE

P407

Q34282217-3B2B354D-A511-480C-B03E-8043C188D1AE

P433

Q34282217-B09DBA3C-958A-4DF7-9F6A-24E0BBAEB3FA

P478

Q34282217-0C0B30CF-8529-4BB2-93FF-A099678FB940

P577

Q34282217-99CE42D7-25B6-406F-A349-760EEA21A638

P5875

Q34282217-21DF4DCA-5A51-45E4-A904-7AD25F3F296E

P698

Q34282217-6F1B9CE6-8B53-4949-BA82-6B8322EE0365

P932

Q34282217-E10945C9-FBB5-4E66-A277-4BC2EBD9B438

P356

BLOOD-2009-10-251058

P1433

P1476

Endogenous dendritic cells med ...... itic cells in transplantation.

@en

P2093

Adrian E Morelli

http://www.w3.org/2001/XMLSchema#string

Adriana T Larregina

http://www.w3.org/2001/XMLSchema#string

Angela Montecalvo

http://www.w3.org/2001/XMLSchema#string

Geza Erdos

http://www.w3.org/2001/XMLSchema#string

Olga A Tkacheva

http://www.w3.org/2001/XMLSchema#string

Quan Liu

http://www.w3.org/2001/XMLSchema#string

Sherrie J Divito

http://www.w3.org/2001/XMLSchema#string

William J Shufesky

http://www.w3.org/2001/XMLSchema#string

Zhiliang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy.

Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients

NK cells promote transplant tolerance by killing donor antigen-presenting cells.

Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.

Tolerogenic dendritic cells and the quest for transplant tolerance.

Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.

P304

2694-2705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-10-251058

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44798870

http://www.w3.org/2001/XMLSchema#string

P698

20576812

http://www.w3.org/2001/XMLSchema#string

P932

2974582

http://www.w3.org/2001/XMLSchema#string